Violetta Rosiek

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Neuroendocrine Tumors

Top Venues

Endokrynologia Polska

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tomasz Krzysztof Bryś, Violetta Rosiek, Beata Rembielak-Stawecka, Marek Rajca, Marek Jerzy Kudla
Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine. Endokrynologia Polska 74 (6) (2024)
Agnes Bocian-Jastrzębska, Anna Malczewska-Herman, Violetta Rosiek, Beata Kos-Kudła
Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms. Cancers 15 (13) (2023)
Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła
Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues. Biomedicines 11 (3) (2023)
Violetta Rosiek, Angelika Kogut, Beata Kos-Kudła
Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm. Cancers 15 (13) (2023)
Violetta Rosiek, Agnes Bocian-Jastrzębska, Beata Kos-Kudła
Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome. Cancers 15 (8) (2023)
Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła
Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues. Biomedicines 11 (3) (2023)
Violetta Rosiek, Ksenia Janas, Magdalena Witkowska, Beata Kos-Kudła
Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms. Journal of clinical medicine 12 (14) (2023)
Violetta Rosiek, Agnes Bocian-Jastrzębska, Beata Kos-Kudła
Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome. Cancers 15 (8) (2023)
Violetta Rosiek, Ksenia Janas
Assessment of VEGF and VEGF R1 serum levels in patients with neuroendocrine neoplasms before and after treatment with first-generation somatostatin analogues. Endokrynologia Polska 73 (3) (2022)
Violetta Rosiek
Sequential therapies in gastric gastrinoma. Endokrynologia Polska 73 (1) (2022)